|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 215/233 | (2006.01) |
| A61K 31/47 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 2408749 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10710748.4 |
| Date of filing the European patent application | 2010-03-19 | |
| (97) | Date of publication of the European application | 2012-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-16 |
| (46) | Date of publication of the claims translation | 2018-09-25 |
| (86) | Number | PCT/US2010/028062 |
| Date | 2010-03-19 |
| (87) | Number | WO 2010/108155 |
| Date | 2010-09-23 |
| (30) | Number | Date | Country code |
| 162130 P | 2009-03-20 | US |
| (72) |
YANG, Xiaoqing, US
HADIDA RUAH, Sara, S., US
GROOTENHUIS, Peter, D.J., US
VAN GOOR, Fredrick, F., US
BOTFIELD, Martyn, C., US
ZLOKARNIK, Gregor, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Cistinės fibrozės transmembraninės konduktazės reguliatoriaus moduliatoriai |
| MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 17 | 347.00 EUR |
| 2027-03-19 |